首页> 外文期刊>Journal of cardiovascular medicine >Red blood distribution width and heart transplantation: any predictive role on patient outcome?
【24h】

Red blood distribution width and heart transplantation: any predictive role on patient outcome?

机译:红细胞分布宽度和心脏移植:对患者结果的任何预测作用?

获取原文
获取原文并翻译 | 示例
           

摘要

Background Red blood cell distribution width (RDW) has been emerging as a strong predictor of mortality among patients with cardiovascular disease. The aim of this study was to verify if RDW is able to predict survival after heart transplantation (HTx). Methods Two hundred and eighteen recipients who underwent HTx between 2000 and 2013 were classified into three groups according to the pre-HTx RDW tertile values (14.6 and 16.4%), and their outcomes were compared. Mean follow-up was 6.6 +/- 4.2 years. Results RDW correlated with other markers of chronic pathological conditions, such as the Index for Mortality Prediction after Cardiac Transplantation (IMPACT) score (P = 0.002) and Charlson Comorbidity Index (P < 0.001), and with creatinine levels (P = 0.007), previous cardiac surgery (P < 0.001), diabetes mellitus (P = 0.02), haemoglobin value (P = 0.004), pulmonary capillary wedge and central venous pressures (P = 0.019 and 0.01, respectively), systolic and mean pulmonary artery pressures (P = 0.002 and 0.014, respectively). The rate of 30-day mortality from the lowest to the highest RDW tertile was 1.4, 4 and 9% (P = 0.02), respectively. Long-term mortality correlated at multivariate analysis with recipient age [hazard ratio 1.06, 95% confidence interval (95% CI) 1.02-1.09], donor age (hazard ratio 1.02, 95% CI 1.0-1.04) and RDW (hazard ratio 1.13, 95% CI 1.04-1.23). The survival probability at 4, 8 and 12 years was 90, 84 and 74% for recipients with RDW less than 14.6%, while it was 72, 60 and 42% for recipients with RDW more than 16.4% (hazard ratio 3.29, 95% CI 1.74-6.24). No differences were found between causes of death. Conclusion RDW correlated with survival in HTx recipients. This marker of blood cell size may represent a surrogate of disease and a helpful tool in the risk-assessment process.
机译:背景技术红色血细胞分布宽度(RDW)已经成为心血管疾病患者中死亡率的强烈预测因子。本研究的目的是验证RDW是否能够在心脏移植(HTX)后的存活率。方法根据前HTX rdw Tertile值(14.6和16.4%)分为三个组的二百十八个接受HTX的接受者分为三组,并比较其结果。平均随访6.6 +/- 4.2岁。结果RDW与慢性病理条件的其他标志物相关,例如心脏移植后死亡率预测的指数(冲击)得分(P = 0.002)和Charlson合并症指数(P <0.001),以及肌酐水平(p = 0.007),先前的心脏手术(P <0.001),糖尿病(P = 0.02),血红蛋白值(P = 0.004),肺毛细管楔形和中央静脉压力(P = 0.019和0.01),收缩和平均肺动脉压力(P分别= 0.002和0.014)。从最低到最高RDW Tertile的30天死亡率分别为1.4,4和9%(p = 0.02)。多元死亡率在多变量分析中与受体年龄进行[危险比1.06,95%置信区间(95%CI)1.02-1.09],供体年龄(危险比1.02,95%CI 1.0-1.04)和RDW(危险比1.13 ,95%CI 1.04-1.23))。 4,8和12岁的生存概率为90,84和74%,接受者的RDW少于14.6%,而RDW的接受者为72,60和42%,超过16.4%(危险比3.29,95% CI 1.74-6.24)。死亡原因之间没有发现差异。结论RDW与HTX受体中存活相关。这种血细胞大小的标记可以代表疾病的替代品和风险评估过程中的有用工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号